Determination of fexofenadine in human plasma using 96-well solid phase extraction and HPLC with tandem mass spectrometric detection.
Determination of fexofenadine in human plasma using 96-well solid phase extraction and HPLC with tandem mass spectrometric detection.
复制标题
使用 96 孔固相萃取和串联质谱检测 HPLC 测定人血浆中的非索非那定。
DOI:
10.1016/j.jpba.2004.02.016
复制
发表时间:
2004
影响因子:
3.4
通讯作者:
B. K. Matuszewski
中科院分区:
文献类型:
--
作者:
I. Fu;E. Woolf;B. K. Matuszewski
A fast and sensitive HPLC–MS/MS method, utilizing atmospheric pressure chemical ionization, for the determination of fexofenadine in human plasma is described. A deuterated analog, d6-fexofenadine is used as the internal standard (IS). Plasma samples are prepared using 96-well solid phase extraction with plates containing Waters Oasis HLB sorbent. The analytes are chromatographed on a Restek Ultra IBD column (3.2 mm ×50 mm, 3μm) using a mobile phase consisting of a mixture of 90% acetonitrile and 10% 10mM ammonium acetate buffer and 0.1% formic acid. Quantitation of the analyte is based on the response from the multiple reaction monitoring of the precursor to product ion pairs for fexofenadine (m/z 502→466) and d6-fexofenadine (m/z 508→472). The assay has been validated over the concentration range of 1–200ng/ml based on the analysis of 0.5ml aliquots of plasma. Within-day assay accuracy was between 97 and 102% of nominal, while within-day precision was better than 3.5% CV at all points on the standard curve. Analyte extraction recovery was better than 70% over the range of the standard curve. The method was found to be suitable for the analysis of human plasma samples obtained 24h following the administration of a single 60mg dose of fexofenadine.
DOI:
--
发表时间:
1999-08
期刊:
Drug metabolism and disposition: the biological fate of chemicals
影响因子:
--
作者:
M. Cvetkovic;B. Leake;M. Fromm;G. Wilkinson;R. Kim
通讯作者:
M. Cvetkovic;B. Leake;M. Fromm;G. Wilkinson;R. Kim